Human immunodeficiency virus and Chagas disease coinfection treated successfully with benznidazole and a raltegravir-based antiretroviral regimen: A case report;Infección combinada por virus de la inmunodeficiencia humana y enfermedad de Chagas tratada satisfactoriamente con benznidazol y una pauta de tratamiento antirretroviral basada en raltegravir: descripción de un caso

Medicina Clinica

Volumn 137, Issue 6, 2011, Pages 278-279

  Rodríguez Guardado, Azucena ^a   Tuset, Montserrat ^b   Asensi, Victor ^a   Miró, José M ^b  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BENZNIDAZOLE; RALTEGRAVIR;

ANTIVIRAL THERAPY; CASE REPORT; CHAGAS DISEASE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LETTER; MIXED INFECTION; TREATMENT OUTCOME;

ADENINE; ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; CHAGAS DISEASE; DRUG INTERACTIONS; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HUMANS; LAMIVUDINE; NITROIMIDAZOLES; OLIGOPEPTIDES; PARAGUAY; PHOSPHONIC ACIDS; PYRIDINES; PYRROLIDINONES; RITONAVIR; SPAIN; TRYPANOCIDAL AGENTS; ZIDOVUDINE;

EID: 80051546425     PISSN: 00257753     EISSN: 15788989     Source Type: Journal    
DOI: 10.1016/j.medcli.2010.06.013     Document Type: Letter

References (10)

1. M. Corti, and C. Yampolsky Prolonged survival and immune reconstitution after chagasic meningoencephalitis in a patient with acquired immunodeficiency syndrome Rev Soc Bras Med Trop 39 2006 85 88
2. Panel de Expertos de GESIDA y Plan Nacional sobre el Sida. 2008 Prevention of opportunistic infections in HIV-infected adolescents and adults guidelines. Recommendations of GESIDA/National AIDS Plan. Enferm Infecc Miocrobiol Clin 2008; 26:437-64.
3. A.M. Caro-Murillo, J. Castilla, S. Pérez-Hoyos, J.M. Miró, D. Podzamczer, and R. Rubio Cohorte RIS de pacientes con infección por VIH sin tratamiento antiretroviral previo (CoRIS): metodología y primeros resultados Enferm Infecc Microbiol Clin 25 2007 23 31 (Pubitemid 46232687)
4. C.L. Karp, and P.G. Auwaerter Coinfection with HIV and tropical infectious diseases. I. Protozoal pathogens Clin Infect Dis 45 2007 1208 1213 (Pubitemid 47580323)
5. J. Raaflaub, and W.H. Ziegler Single-dose pharmacokinetics of the trypanosomicide benznidazole in man Arzneimittelforschung 29 1979 1611 1614 (Pubitemid 10231718)
6. J.A. Castro, M. Montalto de Mecca, and L.C. Bartel Toxic side effects of drugs used to treat Chagas' disease (American Trypanosomiasis) Hum Exp Toxicol 25 2006 471 479 (Pubitemid 44384589)
7. M. Masana, E.G. de Toranzo, and J.A. Castro Reductive metabolism and activation of benznidazole Biochem Pharmacol 33 1984 1041 1045 (Pubitemid 14129027)
8. F.Y. Lee, P. Workman, and K.H. Cheeseman Misonidazole and benznidazole inhibit hydroxylation of CCNU by mouse liver microsomal cytochrome P-450 in vitro Biochem Pharmacol 36 1987 1349 1355 (Pubitemid 17083195)
9. K.E. Dooley, C. Flexner, and A.S. Andreade Drug interactions involving combination of antiretroviral therapy and other anti-infective agents: repercussions for resource-limited countries J Infect Dis 198 2008 948 961
10. K. Kassahun, I. McIntosh, D. Cui, D. Hreniuk, S. Merschman, and K. Lasseter Metabolism and disposition in humans of raltegravir (MK-0518), an anti-AIDS drug targeting the human immunodeficiency virus 1 integrase enzyme Drug Metab Dispos 35 2007 1657 1663 (Pubitemid 47296061)